Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 1,738.00
-62.00 (-3.44%)
Sep 1, 2026, 3:30 PM KST
Aprogen Biologics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 22,428 | 24,393 | 12,306 | 10,053 | 23,609 | 35,074 |
Short-Term Investments | - | - | - | - | 390 | 75,000 |
Trading Asset Securities | 270.51 | 27,240 | 26,013 | - | 75,075 | 14,861 |
Cash & Short-Term Investments | 22,698 | 51,633 | 38,319 | 10,053 | 99,074 | 124,935 |
Cash Growth | -22.21% | 34.75% | 281.15% | -89.85% | -20.70% | -39.08% |
Accounts Receivable | 14,716 | 15,663 | 16,607 | 14,807 | 17,769 | 12,825 |
Other Receivables | 4,498 | 5,344 | 1,682 | 1,828 | 4,256 | 8,259 |
Receivables | 47,604 | 47,930 | 22,972 | 23,373 | 82,060 | 215,755 |
Inventory | 45,242 | 51,601 | 52,286 | 48,128 | 52,313 | 10,420 |
Prepaid Expenses | - | 726.67 | 895.05 | 2,490 | 558.14 | 10.67 |
Other Current Assets | 2,208 | 2,638 | 729.2 | 812.78 | 6,604 | 2,354 |
Total Current Assets | 117,753 | 154,529 | 115,200 | 84,857 | 240,608 | 353,474 |
Property, Plant & Equipment | 313,720 | 322,533 | 321,458 | 318,212 | 323,773 | 18,857 |
Long-Term Investments | 71,104 | 38,920 | 91,994 | 137,647 | 57,793 | 84,232 |
Other Intangible Assets | 3,629 | 5,277 | 5,116 | 6,241 | 6,458 | 2,796 |
Long-Term Accounts Receivable | 18,084 | - | - | - | - | 20,577 |
Long-Term Deferred Tax Assets | - | - | - | - | 662.84 | 755.7 |
Other Long-Term Assets | 24,123 | 24,936 | 3,676 | 3,793 | 10,099 | 9,229 |
Total Assets | 548,413 | 586,993 | 590,984 | 589,397 | 684,140 | 614,621 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4,782 | 3,073 | 1,996 | 1,333 | 3,809 | 652.59 |
Accrued Expenses | 3,990 | 5,000 | 3,756 | 3,747 | 4,968 | 1,201 |
Short-Term Debt | 153,951 | 167,612 | 103,630 | 129,360 | 134,263 | 2,162 |
Current Portion of Long-Term Debt | 4,000 | - | - | - | - | - |
Current Portion of Leases | 2,395 | 2,509 | 2,191 | 1,360 | 345.5 | 199.49 |
Current Income Taxes Payable | - | - | - | - | 4.18 | 273.93 |
Current Unearned Revenue | - | - | - | - | - | 119.99 |
Other Current Liabilities | 37,758 | 50,939 | 35,936 | 22,138 | 17,716 | 4,840 |
Total Current Liabilities | 206,875 | 229,133 | 147,509 | 157,938 | 161,106 | 9,449 |
Long-Term Debt | 36,000 | 40,000 | 32,000 | 32,000 | - | - |
Long-Term Leases | 14,492 | 18,675 | 16,197 | 18,277 | 129.06 | 120 |
Pension & Post-Retirement Benefits | 8,642 | 10,506 | 10,245 | 7,732 | 7,564 | 5,600 |
Long-Term Deferred Tax Liabilities | 5,601 | 5,601 | 3,874 | 2,932 | 3,108 | 1,093 |
Other Long-Term Liabilities | 9,091 | 5,510 | 2,470 | 1,827 | 1,823 | 1,178 |
Total Liabilities | 280,703 | 309,426 | 212,294 | 220,705 | 173,730 | 17,440 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 7,206 | 99,204 | 99,204 | 332,877 | 292,877 | 199,288 |
Additional Paid-In Capital | 708,100 | 704,331 | 704,331 | 358,030 | 335,850 | 327,715 |
Retained Earnings | -334,867 | -409,280 | -239,199 | -133,310 | -8,085 | -21,115 |
Treasury Stock | -4,557 | -4,485 | -4,485 | -4,463 | -41.27 | -41.27 |
Comprehensive Income & Other | -181,642 | -182,014 | -181,360 | -184,443 | -194,079 | 2,092 |
Total Common Equity | 194,239 | 207,757 | 378,491 | 368,691 | 426,521 | 507,939 |
Minority Interest | 73,470 | 69,810 | 199.28 | - | 83,890 | 89,242 |
Shareholders' Equity | 267,710 | 277,567 | 378,691 | 368,691 | 510,411 | 597,181 |
Total Liabilities & Equity | 548,413 | 586,993 | 590,984 | 589,397 | 684,140 | 614,621 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 210,838 | 228,796 | 154,017 | 180,997 | 134,738 | 2,481 |
Net Cash (Debt) | -188,139 | -177,163 | -115,698 | -170,944 | -35,664 | 122,454 |
Net Cash Growth | - | - | - | - | - | -39.41% |
Net Cash Per Share | -14065.58 | -13450.44 | -13796.70 | -40646.99 | -13234.78 | 46085.02 |
Filing Date Shares Outstanding | 13.99 | 13.17 | 13.17 | 4.38 | 3.9 | 2.66 |
Total Common Shares Outstanding | 13.99 | 13.17 | 13.17 | 4.38 | 3.9 | 2.66 |
Working Capital | -89,123 | -74,604 | -32,308 | -73,081 | 79,502 | 344,025 |
Book Value Per Share | 13879.96 | 15773.21 | 28735.58 | 84108.18 | 109224.47 | 191160.18 |
Tangible Book Value | 190,610 | 202,480 | 373,376 | 362,451 | 420,063 | 505,142 |
Tangible Book Value Per Share | 13620.61 | 15372.59 | 28347.19 | 82684.48 | 107570.66 | 190107.77 |
Land | 38,541 | 38,461 | 29,664 | 25,156 | 28,315 | 9,313 |
Buildings | 79,351 | 102,328 | 97,599 | 97,507 | 101,378 | 9,647 |
Machinery | 148,793 | 225,657 | 179,320 | 118,620 | 145,738 | 10,258 |
Construction In Progress | 30,988 | 30,975 | 64,463 | 108,996 | 90,433 | - |